5076 - 5100 of 6230 Results
Title
Year
- Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in Humans2022OPENTitle: Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in HumansJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 87Issue #: 3Start Page: 1251End Page: 1290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-220071Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9268955Citation Count: 18
- Evolution of Prodromal Multiple System Atrophy from REM Sleep Behavior Disorder: A Descriptive Study2022OPENTitle: Evolution of Prodromal Multiple System Atrophy from REM Sleep Behavior Disorder: A Descriptive StudyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 983End Page: 991Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213039Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9789475Citation Count: 14
- Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder2022OPENTitle: Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior DisorderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 927End Page: 933Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212984Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212984?id=journal-of-parkinsons-disease%2Fjpd212984Citation Count: 2
- Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical Trial2021OPENTitle: Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson’s Disease: Interim Results from a Randomized Double-Blind Clinical TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 639End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212793Best OA location URL: https://hal.sorbonne-universite.fr/hal-03962391/file/Bourilhon%2CJParkDis_2021.pdfCitation Count: 10
-
OPENTitle: Determinants of Self-Stigma in People with Parkinson’s Disease: A Mixed Methods Scoping ReviewJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 509End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212869Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212869?id=journal-of-parkinsons-disease%2Fjpd212869Citation Count: 22
-
OPENTitle: Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged PopulationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 967End Page: 974Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213007Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213007?id=journal-of-parkinsons-disease%2Fjpd213007Citation Count: 36
- A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study2021OPENTitle: A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 137End Page: 151Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202457Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202457?id=journal-of-parkinsons-disease%2Fjpd202457Citation Count: 28
- Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury2022OPENTitle: Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain InjuryJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.813387Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2022.813387/pdfCitation Count: 30
- Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system2022OPENTitle: Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune systemJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2022.1056417Best OA location URL: https://doi.org/10.3389/fimmu.2022.1056417Citation Count: 23
- Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies2022OPENTitle: Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding RibosomopathiesJournal Name: Frontiers in Molecular BiosciencesPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmolb.2022.805541Best OA location URL: https://doi.org/10.3389/fmolb.2022.805541Citation Count: 4
-
OPENTitle: Editorial: Digital Innovation and Data-Driven Research in Neurodegenerative DiseasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.961847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.961847/pdfCitation Count: 0
- The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II2022OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.994114/pdfCitation Count: 4
- Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis2022OPENTitle: Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.927573Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.927573/pdfCitation Count: 3
- OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE2022OPENTitle: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBEJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.914486Best OA location URL: https://doi.org/10.3389/fneur.2022.914486Citation Count: 7
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 9
- Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia2022OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://doi.org/10.3389/fneur.2022.846126Citation Count: 5
- Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study2022OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 10
- The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program2022OPENTitle: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1036068Best OA location URL: https://doi.org/10.3389/fneur.2022.1036068Citation Count: 19
- Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease2022OPENTitle: Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.889647Best OA location URL: https://doi.org/10.3389/fneur.2022.889647Citation Count: 38
- Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health System2022OPENTitle: Trends in the Utilization of Teleneurology and Other Healthcare Resources Prior to and During the COVID-19 Pandemic in an Urban, Tertiary Health SystemJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834708Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834708/pdfCitation Count: 9
- Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells2022OPENTitle: Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1114775Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1114775/pdfCitation Count: 1
-
OPENTitle: Editorial: LRRK2—Fifteen Years From Cloning to the ClinicJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.880914Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.880914/pdfCitation Count: 1
- Parkinson's disease resting tremor severity classification using machine learning with resampling techniques2022OPENTitle: Parkinson's disease resting tremor severity classification using machine learning with resampling techniquesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.955464Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.955464/pdfCitation Count: 4
-
OPENTitle: Targeting the inflammasome in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.957705Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.957705/pdfCitation Count: 17
- Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity2022OPENTitle: Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal IntegrityJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.930315Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.930315/pdfCitation Count: 15